Sundar PichaiSundar Pichai earned $164M in 2023
L

Elizabeth Homans

Ex-CEO of Lyell Immunopharma, Inc.

Education

MBA from Harvard Business School

Field of Expertise

Business & Management

Born

January 1, 1978 - 47 years ago

Economy Sector

Healthcare

Tenure

1 year 2 months (Sep 2021 - Dec 2022)

Previous Experience

Former Chief Operating Officer at Lyell Immunopharma, Inc.

Elizabeth Homans is a business-focused leader with an MBA from Harvard Business School. She was the CEO of Lyell Immunopharma, Inc. until December 2022. During her time at Lyell, she made significant contributions to the company's strategic goals. Notably, she...

Year

2022

Total Compensation

$1.86M

Salary

$600.00K

Board Justification

The compensation philosophy is designed to attract and retain talented individuals who possess the skills necessary to manage and grow the business, facilitate the achievement of strategic goals, and create long-term value for stockholders.

Bonus

$360.00K

Board Justification

In connection with her termination of employment, Ms. Homans was paid $360,000, equal to 100% of her target bonus amount for 2022, as part of her severance benefits.

Other

$900.00K

Board Justification

In addition to her salary and bonus, Ms. Homans received a cash payment of $900,000, which constitutes the equivalent of 18 months of her annual base salary in effect as of the date of her termination of employment.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock was reported as vested in 2022 for Elizabeth Homans.

Performance Metrics

The performance metrics for determining the compensation included corporate goals related to advancing therapies and managing financial resources.